Pharmafile Logo

Dietary Management

- PMLiVE

Diversity in Clinical Trials : A more inclusive approach in patient recruitment

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient...

- PMLiVE

Eating Disorders Awareness Week

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders

Innovative Trials

Social Health Prescription: Connecting People, Empowering Patients, & Improving Outcomes

Lynda Brown-Ganzert, Founder & CEO of Curatio, discusses the concept of social health prescription and the inspiration behind Curatio. She also explores questions such as how AI and “intelligent matchmaking” can be leveraged...

Impetus Digital

- PMLiVE

NICE recommends GSK’s Zejula for patients with ovarian cancer

In the UK there are over 40,000 women with ovarian cancer

Takeda agrees on $2bn deal with Code Bio to expand its gene therapy programmes

The pharma company will gain opt-in rights for four rare diseases candidates

A Lucid Group social

The newly formed Lucid Social Committee is launching its first event for the year: Today, on Thursday 24 February Lucid will be hosting its inaugural board games night in both...

Lucid Group Communications Limited

Rare Disease Day logo

Welcome to the era of the orphan drug

As we approach Rare Disease Day on 28 February, we look back at how the rare disease landscape has evolved over the last few decades.

Sciterion

- PMLiVE

London High Court rules in favour of NHS in Servier drug dispute

The judgement is a key milestone in the 11-year case between the French pharmaceutical company and the secretary of state for health and social care and the wider NHS

- PMLiVE

Eli Lilly launches the Institute for Genetic Medicine and a $700m facility investment

The US state-of-the-art facility will further the development of RNA and DNA-based treatments

New syndicated patient report – Living with Lupus US

Living with Lupus US is a new syndicated patient report which offers valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.

Inizio

- PMLiVE

England to end COVID-19 isolation laws and mass free testing

From 24 February, all COVID-19 restrictions will end in England and from 1 April, all free mass testing will finish

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links